Apellis Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APLS Nasdaq 2830 www.apellis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apellis Pharmaceuticals, Inc.

Is Apellis Pharmaceuticals, Inc. (APLS) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Apr 23rd, 2025 4:56 pm
Apellis Announces Craig Wheeler to Join the Board of Directors - Apr 21st, 2025 11:00 am
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock? - Apr 15th, 2025 11:20 am
APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag - Apr 2nd, 2025 1:11 pm
FDA accepts priority review of Apellis’ Empaveli sNDA for kidney diseases - Apr 2nd, 2025 8:55 am
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN - Apr 1st, 2025 11:00 am
Exploring US High Growth Tech Stocks In March 2025 - Mar 31st, 2025 5:08 pm
Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts - Mar 25th, 2025 9:41 pm
Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli - Mar 22nd, 2025 3:41 pm
Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst - Mar 5th, 2025 7:04 pm
Apellis Q4 Loss Narrower Than Expected, Syfovre Sales Drive Revenues - Mar 3rd, 2025 3:56 pm
Apellis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations - Mar 1st, 2025 12:48 pm
Apellis Pharmaceuticals Inc (APLS) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and ... - Mar 1st, 2025 7:08 am
Q4 2024 Apellis Pharmaceuticals Inc Earnings Call - Mar 1st, 2025 6:29 am
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q4 Earnings: A Look at Key Metrics - Feb 28th, 2025 2:30 pm
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates - Feb 28th, 2025 1:15 pm
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 28th, 2025 12:05 pm
Y-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Feb 25th, 2025 3:00 pm
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Feb 24th, 2025 12:00 pm
Why Apellis Pharmaceuticals, Inc. (APLS) is the Most Oversold Pharma Stock to Buy According to Analysts - Feb 23rd, 2025 6:31 pm